Results 101 to 110 of about 794,451 (306)

'Notice and staydown' and social media: amending Article 13 of the Proposed Directive on Copyright [PDF]

open access: yes, 2018
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits ...
Romero Moreno, Felipe
core   +2 more sources

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

Fair Trial as the Foundation for Court Ethics

open access: yesZbornik Radova Pravnog Fakulteta u Splitu, 2012
('After introductory commentary wherein, among other things, it is stated that the conventional', 'right to fair trial is also applicable to administrative courts which in the Republic of Croatia are a', 'constituent part of judicial power, the author ...
Boris Ljubanović
doaj  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

The cuts to legal aid are obstructing the right to a fair trial and preventing the administration of justice [PDF]

open access: yes, 2014
In an astounding blow to the government’s decision to drastically cut access to legally-aided counsel, a judge yesterday ordered a stay (rather than an adjournment) to a complex fraud case as the defendants could find no lawyers to take the case.
Gearty, Conor
core  

Incompatibility of the Digital Economy Act 2010 subscriber appeal process provisions with Article 6 of the ECHR [PDF]

open access: yes, 2014
This is the accepted manuscript of an article published by Taylor & Francis in International Review of Law, Computers and Technology on 10 January 2014. The version of record [Romero-Moreno, F.
Felipe Romero Moreno   +5 more
core   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Court interpreting in Italy. The daily violation of a fundamental human right [PDF]

open access: yes, 2012
The paper analyses the situation of court interpreting in Italy and examines three cases of blatant violation of the defendants’ right to a fair ...
Garwood, Christopher John
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy